Evidence map›Paper›PMID 39788726›Full record

ArticleTropical medicine & international health : TM & IH2025

Progress towards the elimination of trachoma as a public health problem in four counties of Eastern Equatoria State, Republic of South Sudan.

Stephen Ohidor, Nicholas A Presley, Angelia M Sanders, Andrew W Nute, Tania A Gonzalez, Yak Yak Bol, Albino W Nyibong, Paul Weiss, James Niquette, E Kelly Callahan and 1 more

Abstract read
In one paragraph

Article in Tropical medicine & international health : TM & IH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stephen OhidorThe Carter Center - South Sudan, The Carter Center, Juba, Central Equatoria State, South Sudan.
Nicholas A PresleyTrachoma Control Program, The Carter Center, Atlanta, Georgia, USA.ORCID https://orcid.org/0009-0000-6593-9244
Angelia M SandersTrachoma Control Program, The Carter Center, Atlanta, Georgia, USA.
Andrew W NuteTrachoma Control Program, The Carter Center, Atlanta, Georgia, USA.
Tania A GonzalezTrachoma Control Program, The Carter Center, Atlanta, Georgia, USA.
Yak Yak BolDepartment of PC-NTD, Ministry of Health, Republic of South Sudan, Juba, Central Equatoria State, South Sudan.
Albino W NyibongDepartment of Eye Care, Ministry of Health, Republic of South Sudan, Juba, Central Equatoria State, South Sudan.
Paul WeissIndependent Contractor, Bogart, Georgia, USA.
James NiquetteThe Carter Center - South Sudan, The Carter Center, Juba, Central Equatoria State, South Sudan.
E Kelly CallahanTrachoma Control Program, The Carter Center, Atlanta, Georgia, USA.
Scott D NashTrachoma Control Program, The Carter Center, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0001-5741-8537

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTrachoma is targeted by the World Health Organization (WHO) for elimination as a public health problem by 2030. Trachoma impact surveys using standardised methodology are recommended to monitor progress towards elimination and to determine eligibility for continued surgery, antibiotics, facial cleanliness, and environmental improvement (SAFE) interventions. From 2007 to 2015, four counties of Eastern Equatoria State, South Sudan, received three to five rounds of mass drug administration with antibiotics. A trachoma impact survey in 2015 indicated all four counties had trachomatous-inflammation follicular prevalence among children ages 1-9 years above the WHO elimination threshold (range 17.4%-47.6%). Based on these results, the recommended number of years of SAFE interventions were implemented and the counties were subsequently resurveyed.

methodsBetween 2021 and 2023, trachoma impact surveys were conducted in Budi, Kapoeta East, Kapoeta North, and Kapoeta South counties using a two-stage cluster sample design. Trained and certified graders examined participants for trachoma clinical signs using the WHO simplified grading system to estimate county-level prevalence.

resultsA total of 12,570 individuals from 3286 households in 116 survey clusters were examined for trachoma. Prevalence of trachomatous-inflammation follicular among children ages 1-9 years was 5.6% (95% confidence interval [CI]:3.7%-8.3%) in Kapoeta South, 7.4% (CI:5.1%-10.7%) in Budi, 12.3% (CI:7.8%-18.9%) in Kapoeta East, and 18.1% (CI:13.5%-24.0%) in Kapoeta North. Trachomatous inflammation-intense prevalence among children ages 1-9 years ranged from 0.4% (CI:0.2%-1.0%) in Kapoeta East to 2.1% (CI:1.4%-3.2%) in Kapoeta North, and trachomatous trichiasis in individuals ages ≥15 years ranged from 1.0% (CI:0.5%-2.1%) in Kapoeta North to 1.9% (CI:1.3%-2.8%) in Budi.

conclusionsAs no county reached the WHO elimination thresholds of trachomatous-inflammation follicular <5% or trachomatous trichiasis <0.2%, SAFE interventions should continue. Furthermore, these districts are classified as having persistent trachoma, based on trachomatous-inflammation follicular levels remaining >5% after two impact surveys. Compared to results from 2015, the prevalence of trachomatous-inflammation follicular, trachomatous inflammation-intense, and trachomatous trichiasis in all counties decreased, indicating that the Republic of South Sudan Ministry of Health's Trachoma Control Program is advancing towards its elimination goal.

Indexed as

Anti-Bacterial AgentsDisease EradicationPublic HealthTrachomaAdolescentAdultChildChild, PreschoolFemaleHumansInfantMaleMass Drug AdministrationPrevalenceSouth SudanAnti-Bacterial AgentsEastern Equatoria Stateelimination as a public health problemSAFE strategySouth Sudantrachomatrachoma impact surveys

Identifiers

PMID39788726
PMCPMC11873754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.